CCI study: Team cuts CHD patient radiation exposure by 61% | Study finds similar 10-year stroke protection with stenting, endarterectomy | Study: Revascularization with FFR guidance has safety benefits
Web Version
October 21, 2014
SCAI SmartBrief
News for Invasive/Interventional Cardiologists

Top Stories
CCI study: Team cuts CHD patient radiation exposure by 61%
Patients with congenital heart disease who underwent catheterization at the Mayo Clinic were exposed to 61% less cumulative radiation under a new approach developed by the clinic's cardiologists. The team established a radiation safety board as part of a series of practice changes and instituted technical protocols such as changing default fluoroscopy settings. The findings were published in Catheterization and Cardiovascular Interventions. (10/20)
Share: LinkedInTwitterFacebookGoogle+Email
Study finds similar 10-year stroke protection with stenting, endarterectomy
Carotid artery stenting and endarterectomy provide similar protection against stroke over 10 years, leaving cardiologists to decide which treatment is best for a given patient, according to a study published in The Lancet. The randomized trial compared the two procedures for treatment of symptomatic atherosclerotic carotid stenosis. Commenting on the findings, Dr. William Gray of Columbia University Medical Center said the study "recapitulates much of what we saw in CREST," but reimbursement issues complicate the landscape. (10/17), (10/14)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Policy & Professional News
Cardiologists weigh in on the benefits, frustrations of EHRs
The mandated transition to EHRs is getting mixed reviews from cardiologists, who say they appreciate quick access to reports and images but are frustrated by the systems' limitations. "Interventional cardiology and the entire cardiology spectrum tend to be very data intensive and data rich," said Duke University's Dr. James Tcheng. However, he said EHRs have little ability to manage and capitalize on the available information. Time spent on electronic records also is a concern, said SCAI Past President Dr. J. Jeffrey Marshall. "Doctors are now doing what in the past was completed by clerks or medical assistants," Marshall said. (10/20)
Share: LinkedInTwitterFacebookGoogle+Email
CDC issues new Ebola guidelines for health care workers
The CDC has released new guidelines for health care workers treating patients with Ebola. The new guidelines stress the use of protective garments, requiring workers to be "repeatedly trained" when it comes to putting on and taking off their personal protective equipment, leaving no skin exposed while caring for infected patients. All workers will be supervised by a trained observer or site manager to ensure protective protocols are followed while removing and putting on protective gear. NBC News (10/20), ABC News/The Associated Press (10/20), National Public Radio/The Two-Way blog (10/20)
Share: LinkedInTwitterFacebookGoogle+Email
Medical Developments
Hospital tries newly approved drug-coated balloon catheter for PAD
Three Mount Sinai Hospital doctors were the first in the nation to perform angioplasty using a drug-coated balloon catheter approved this month for the treatment of peripheral arterial disease. The Lutonix 035 drug-coated balloon catheter is designed for use in PAD patients with severely blocked femoro-popliteal arteries. The device releases paclitaxel to the wall of the vessel as it unblocks the obstructed artery. Healio (free registration)/Cardiology Today (10/19)
Share: LinkedInTwitterFacebookGoogle+Email
Medical device coating resists blood clots and bacterial growth
Harvard University researchers have developed a coating for medical devices that blocks the formation of blood clots and biofilms on 20 tested materials. Implants with the tethered-liquid perfluorocarbon coating were tested in pig blood vessels without heparin, according to the study in the journal Nature Biotechnology. (10/12)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Don't miss SCAI's evidence-based, unbiased education in transradial and CTO interventions
Looking for evidence-based, unbiased education in transradial and/or CTO interventions taught by the leading experts on the topics? Then look no further than the SCAI TRIP and CTO courses in Los Angeles on Nov. 15 and 16, respectively. For your convenience, SCAI is offering a $100 discount if you attend both. Both courses will offer basic and advanced content and are a great educational opportunity for the whole cath lab team. Learn more and make plans to attend.
Share: LinkedInTwitterFacebookGoogle+Email
Reminder: SCAI 2015 abstract deadline is just a month away
Want to reach the leading figures in the interventional and invasive cardiology community with your research? Want your work published in Interventional Cardiology's leading journal, Catheterization & Cardiovascular Interventions? Then be sure to submit your abstract(s) to SCAI 2015 Scientific Sessions, where interventional and invasive cardiology meet! In addition to being published in CCI, all accepted abstract presenters receive free registration to SCAI 2015. Submit your abstract prior to the Nov. 27 deadline.
Share: LinkedInTwitterFacebookGoogle+Email
Nobody can go back and start a new beginning, but anyone can start today and make a new ending."
-- Maria Robinson,
American author
Share: LinkedInTwitterFacebookGoogle+Email
The news summaries appearing in SCAI SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI SmartBrief constitute the official opinion of SCAI.
The SCAI SmartBrief news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI SmartBrief may be directed to SmartBrief at
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Melissa Turner
Advertising:  Wynn Hansen
  P: 202.470.1149

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information